Cargando…

PD4-1-3 A result of questionnaire about COVID-19 and chemotherapy, for patients utilizing outpatient chemotherapy center

Detalles Bibliográficos
Autores principales: Shibata, Takashi, Ishimabushi, Yuki, Suzuki, Masato, Uchida, Toshiki, Sakamoto, Eiji, Ogasawara, Tomohiko, Yamamuro, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311565/
http://dx.doi.org/10.1016/j.annonc.2021.05.557
_version_ 1783728983619141632
author Shibata, Takashi
Ishimabushi, Yuki
Suzuki, Masato
Uchida, Toshiki
Sakamoto, Eiji
Ogasawara, Tomohiko
Yamamuro, Osamu
author_facet Shibata, Takashi
Ishimabushi, Yuki
Suzuki, Masato
Uchida, Toshiki
Sakamoto, Eiji
Ogasawara, Tomohiko
Yamamuro, Osamu
author_sort Shibata, Takashi
collection PubMed
description
format Online
Article
Text
id pubmed-8311565
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-83115652021-07-26 PD4-1-3 A result of questionnaire about COVID-19 and chemotherapy, for patients utilizing outpatient chemotherapy center Shibata, Takashi Ishimabushi, Yuki Suzuki, Masato Uchida, Toshiki Sakamoto, Eiji Ogasawara, Tomohiko Yamamuro, Osamu Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2021-07 2021-07-26 /pmc/articles/PMC8311565/ http://dx.doi.org/10.1016/j.annonc.2021.05.557 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Shibata, Takashi
Ishimabushi, Yuki
Suzuki, Masato
Uchida, Toshiki
Sakamoto, Eiji
Ogasawara, Tomohiko
Yamamuro, Osamu
PD4-1-3 A result of questionnaire about COVID-19 and chemotherapy, for patients utilizing outpatient chemotherapy center
title PD4-1-3 A result of questionnaire about COVID-19 and chemotherapy, for patients utilizing outpatient chemotherapy center
title_full PD4-1-3 A result of questionnaire about COVID-19 and chemotherapy, for patients utilizing outpatient chemotherapy center
title_fullStr PD4-1-3 A result of questionnaire about COVID-19 and chemotherapy, for patients utilizing outpatient chemotherapy center
title_full_unstemmed PD4-1-3 A result of questionnaire about COVID-19 and chemotherapy, for patients utilizing outpatient chemotherapy center
title_short PD4-1-3 A result of questionnaire about COVID-19 and chemotherapy, for patients utilizing outpatient chemotherapy center
title_sort pd4-1-3 a result of questionnaire about covid-19 and chemotherapy, for patients utilizing outpatient chemotherapy center
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311565/
http://dx.doi.org/10.1016/j.annonc.2021.05.557
work_keys_str_mv AT shibatatakashi pd413aresultofquestionnaireaboutcovid19andchemotherapyforpatientsutilizingoutpatientchemotherapycenter
AT ishimabushiyuki pd413aresultofquestionnaireaboutcovid19andchemotherapyforpatientsutilizingoutpatientchemotherapycenter
AT suzukimasato pd413aresultofquestionnaireaboutcovid19andchemotherapyforpatientsutilizingoutpatientchemotherapycenter
AT uchidatoshiki pd413aresultofquestionnaireaboutcovid19andchemotherapyforpatientsutilizingoutpatientchemotherapycenter
AT sakamotoeiji pd413aresultofquestionnaireaboutcovid19andchemotherapyforpatientsutilizingoutpatientchemotherapycenter
AT ogasawaratomohiko pd413aresultofquestionnaireaboutcovid19andchemotherapyforpatientsutilizingoutpatientchemotherapycenter
AT yamamuroosamu pd413aresultofquestionnaireaboutcovid19andchemotherapyforpatientsutilizingoutpatientchemotherapycenter